Wei-Yan You
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei-Yan You has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Jun Gao
Department of Neurobiology, School of Basic Medical Science, Nanjing Medical University, Nanjing, China
3 shared publications - Chuan He
Department of Rehabilitation Medicine, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou, China
2 shared publications Cui Qi
Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China
2 shared publicationsRui Liu
Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China
2 shared publications- Cui Qi
Nanjing Medical University Department of Neurobiology, School of Basic Medical Science Longmian Road 101, Jiangning District, Nanjing 211166, China
1 shared publication Jia-Qi Zhang
Department of Neurobiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 9 February 2024
- Published by Springer Nature in Molecular Brain
- Vol. 17 (1) , 1-5
Correction: The deficiency of Maged1 attenuates Parkinson’s disease progression in mice
- 9 February 2024
- Published by Springer Nature in Molecular Brain
- Vol. 17 (1) , 1-5
Open AccessCorrection: The deficiency of Maged1 attenuates Parkinson’s disease progression in mice
- Open Access
- 11 February 2023
- Published by Springer Nature in Molecular Brain
- Vol. 16 (1) , 1-16
The deficiency of Maged1 attenuates Parkinson's disease progression in mice
Melanoma-associated antigen D1 (Maged1) has critical functions in the central nervous system in both developmental and adult stages. Loss of Maged1 in mice has been linked to depression, cognitive disorder, and drug addiction. However, the role of Maged1 in Parkinson’s disease (PD) remains unclear. In this study, we observed that Maged1 was expressed in the dopaminergic (DA) neurons of the substantia nigra in mice and humans, which could be upregulated by the in vivo or in vitro treatment with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-Methyl-4-phenylpyridinium iodide (MPP+). Genetic ablation of Maged1 in mice attenuated motor deficits, the loss of DA neurons, and disease progression induced by MPTP. Moreover, Maged1 deficiency protected DA neurons against MPP+-induced toxicity in primary cultured cells. Mechanistically, loss of Maged1 upregulated the Akt signaling pathway and downregulated the mTOR signaling pathway in SH-SY5Y cells, which may in turn attenuate the cell apoptosis and impairment of autophagy. Consistent with it, the degeneration of midbrain and striatum among elderly Maged1 knockout mice was relatively mild compared to those in wild-type mice under physiological conditions. Taken together, this study suggested that Maged1 deficiency inhibited apoptosis and enhanced autophagy, which may provide a new potential target for the therapy of PD.
- 11 February 2023
- Published by Springer Nature in Molecular Brain
- Vol. 16 (1) , 1-16
Open AccessThe deficiency of Maged1 attenuates Parkinson's disease progression in mice
Melanoma-associated antigen D1 (Maged1) has critical functions in the central nervous system in both developmental and adult stages. Loss of Maged1 in mice has been linked to depression, cognitive disorder, and drug addiction. However, the role of Maged1 in Parkinson’s disease (PD) remains unclear. In this study, we observed that Maged1 was expressed in the dopaminergic (DA) neurons of the substantia nigra in mice and humans, which could be upregulated by the in vivo or in vitro treatment with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or 1-Methyl-4-phenylpyridinium iodide (MPP+). Genetic ablation of Maged1 in mice attenuated motor deficits, the loss of DA neurons, and disease progression induced by MPTP. Moreover, Maged1 deficiency protected DA neurons against MPP+-induced toxicity in primary cultured cells. Mechanistically, loss of Maged1 upregulated the Akt signaling pathway and downregulated the mTOR signaling pathway in SH-SY5Y cells, which may in turn attenuate the cell apoptosis and impairment of autophagy. Consistent with it, the degeneration of midbrain and striatum among elderly Maged1 knockout mice was relatively mild compared to those in wild-type mice under physiological conditions. Taken together, this study suggested that Maged1 deficiency inhibited apoptosis and enhanced autophagy, which may provide a new potential target for the therapy of PD.
- Open Access
- 21 May 2019
- Published by Springer Nature in Molecular Brain
- Vol. 12 (1) , 1-12
A protein phosphatase 2A deficit in the hippocampal CA1 area impairs memory extinction
Protein phosphorylation plays an important role in learning and memory. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase involved in the regulation of neural synaptic plasticity. Here, to determine if PP2A is necessary for successful learning and memory, we have utilized a Tg (Camk2a-cre) T29–2Stl mice to specific knock down the expression of hippocampal PP2A in mice. By analysing behavioural, we observed that loss of PP2A in the hippocampal CA1 area did not affect the formation of memory but impaired contextual fear memory extinction. We use the electrophysiological recording to find the synaptic mechanisms. The results showed that the basic synapse transmission and synaptic plasticity of PP2A conditional knockout (CKO) mice were impaired. Moreover, PP2A CKO mice exhibited a saturating long-term potentiation inducted by strong theta burst stimulation but no depotentiation after low-frequency stimulation. Taken together, our results provide the evidence that PP2A is involved in synaptic transmission and hippocampus-dependent memory extinction.
- 21 May 2019
- Published by Springer Nature in Molecular Brain
- Vol. 12 (1) , 1-12
Open AccessA protein phosphatase 2A deficit in the hippocampal CA1 area impairs memory extinction
Protein phosphorylation plays an important role in learning and memory. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase involved in the regulation of neural synaptic plasticity. Here, to determine if PP2A is necessary for successful learning and memory, we have utilized a Tg (Camk2a-cre) T29–2Stl mice to specific knock down the expression of hippocampal PP2A in mice. By analysing behavioural, we observed that loss of PP2A in the hippocampal CA1 area did not affect the formation of memory but impaired contextual fear memory extinction. We use the electrophysiological recording to find the synaptic mechanisms. The results showed that the basic synapse transmission and synaptic plasticity of PP2A conditional knockout (CKO) mice were impaired. Moreover, PP2A CKO mice exhibited a saturating long-term potentiation inducted by strong theta burst stimulation but no depotentiation after low-frequency stimulation. Taken together, our results provide the evidence that PP2A is involved in synaptic transmission and hippocampus-dependent memory extinction.